| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Adalimunab 40mg/mL injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Cromolyn sodium 100mg/5ml oral concentrate solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Sodium cromoglycate+isoprenaline sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing cromoglicate sodium and salbutamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Sodium cromoglycate 2% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing pizotifen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing sodium cromoglycate in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Inhaled sodium cromoglycate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing sodium cromoglycate in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Ergot alkaloid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Ergotamine + caffeine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Duloxetine 20mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Duloxetine 40mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Etanercept 25mg powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Aromatic analgesic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing cromoglicic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing ergotamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing cromolyn sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Desiccated liver preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| analgésique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing isometheptene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Injectable liver preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing ergotamine tartrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing liver extract (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely duloxetine (as duloxetine hydrochloride) 60 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Duloxetine (as duloxetine hydrochloride) 30 mg gastro-resistant oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Aromatic analgesic poisoning NEC |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Aromatic analgesic poisoning NOS |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| [X]Poisoning by other analgesics, not elsewhere classified |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Analgesic poisoning, NEC |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Sodium cromoglycate [gastro-intestinal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Sodium cromoglycate [asthma] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Sodium cromoglycate compounds |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Hepacon liver extract D 0.1mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing pizotifen in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing ergotamine tartrate in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Isometheptene-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Topical anti-inflammatory prep[1] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Topical anti-inflammatory prep[2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Other preps for inflamed joints |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Sodium cromoglycate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| agent anti-inflammatoire |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Sodium cromoglycate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing duloxetine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Adalimumab 40mg injection solution 0.8mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Ergotamine tartrate 2 mg sublingual tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Cromolyn sodium 20mg/2 mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Liver derivative complex 25.5mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Cromolyn sodium 0.8mg/inh |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Cromolyn sodium 20mg/amp solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Cromolyn sodium 100mg/5mL gas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Cromolyn sodium 5.2mg/spr solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Cromolyn sodium 10mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Cromolyn sodium 800mcg/inh |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Cromolyn sodium 40mg/spr solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Cromolyn sodium 8.1g spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Cromolyn sodium 40mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Cromolyn sodium 0.8mg/spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Ophthalmic cromolyn sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Etanercept 50mg powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Agent for migraine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing caffeine and ergotamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Isometheptene mucate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing adalimumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing belladonna alkaloids and ergotamine tartrate and phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Sodium cromoglycate+xylometazoline hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing tumor necrosis factor alpha inhibitor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| agent pour le traitement de la migraine |
Is a |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Product containing infliximab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Infliximab 100 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Poisoning caused by analgesic, antipyretic AND/OR antirheumatic |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| [X]Analgesics, antipyretics and anti-inflammatory drugs causing adverse effects in therapeutic use |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| [X]Antirheumatics causing adverse effects in therapeutic use |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| [X]Other analgesics, antipyretics and anti-inflammatory drugs causing adverse effects in therapeutic use |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| [X]Unspecified analgesics, antipyretics and anti-inflammatory drugs causing adverse effects in therapeutic use |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Poisoning caused by opiate AND/OR related narcotic |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Overdose of analgesic drug |
Causative agent (attribute) |
True |
Analgesic (substance) |
Inferred relationship |
Some |
1 |
| Overdose of combination analgesic |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Overdose of combination analgesic of undetermined intent |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Poisoning caused by analgesic AND/OR antipyretic |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Intentional combined analgesic overdose |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Adverse reaction caused by analgesics, antipyretics and antirheumatics |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Unspecified opium poisoning |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Opiate or narcotic poisoning NOS |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Other non-narcotic analgesic poisoning |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Non-narcotic analgesic poisoning NOS |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Other analgesic and antipyretic poisoning |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Other analgesic or antipyretic poisoning NOS |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Analgesic, antipyretic or antirheumatic poisoning NOS |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to other analgesics, anti-pyretics and anti-rheumatics |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to other analgesics, anti-pyretics and anti-rheumatics NOS |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to analgesics, anti-pyretics and anti-rheumatics NOS |
Causative agent (attribute) |
False |
Analgesic (substance) |
Inferred relationship |
Some |
|
| Nitrous oxide and oxygen gas analgesia in labor (procedure) |
Direct substance |
False |
Analgesic (substance) |
Inferred relationship |
Some |
1 |
| Gas and air analgesia in labor |
Direct substance |
False |
Analgesic (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]